Medartis Holding AG (XSWX:MED) Current Accrued Expense: CHF0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MED Medartis Holding AG XSWX:MED
82 GF Score
Price CHF88.20
GF Value CHF102.41
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medartis Holding AG Current Accrued Expense?

Medartis Holding AG XSWX:MED +0.80% 82 Current Accrued Expense is CHF0.0 Mil as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 82/100 and a GF Value™ of CHF102.41 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Medartis Holding AG's Current Accrued Expense for the quarter that ended in Dec. 2025 was CHF0.0 Mil.

Medartis Holding AG Current Accrued Expense Related Terms

Medartis Holding AG Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Current Accrued Expense Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:MED
82GF Score
Medartis Holding AG XSWX:MED
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of CHF0.0 Mil mean?
Medartis Holding AG (XSWX:MED) has a Current Accrued Expense of CHF0.0 Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Medartis Holding AG and its competitors.
Is Medartis Holding AG's Current Accrued Expense too high?
Medartis Holding AG's current Current Accrued Expense is CHF0.0 Mil. Overall, Medartis Holding AG has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Current Accrued Expense compare to ABT and SYK?
Medartis Holding AG's Current Accrued Expense of CHF0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current Current Accrued Expense is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF102.41, compared to a current price of CHF88.20 — trading 13.9% below its estimated fair value. The current Current Accrued Expense is CHF0.0 Mil. Medartis Holding AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Current Accrued Expense is CHF0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF88.20 is trading 13.9% below its estimated GF Value™ of CHF102.41. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • Current Accrued Expense: CHF0.0 Mil
  • GF Value™: CHF102.41 vs. price of CHF88.20 (13.9% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score

Get the complete analysis for XSWX:MED

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF88.20
Price
CHF102.41
GF Value